Agenus, Inc. (AGEN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1149895,
    "name": "Agenus, Inc.",
    "stock_name": "Agenus, Inc.",
    "full_name": "Agenus, Inc.",
    "name_url": "stocks-analysis/agenus-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "4.06",
    "chg": -0.11,
    "chgp": "-2.64%",
    "dir": -1,
    "prev_price": "4.17",
    "mcapval": "135.74",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US00847G7051",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.03 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/agenus-inc-1149895-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Agenus, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-agenus-inc-technically-bullish-or-bearish-3545754",
        "imagepath": "",
        "date": "2025-09-20 19:17:53",
        "description": "As of 3 September 2025, the technical trend for Agenus, Inc. has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly MACD and Bollinger Bands are mildly bearish, creating a mixed signal. The monthly MACD and KST are mildly bullish, suggesting some positive momentum over a longer time frame. Overall, the technical stance is mildly bullish, driven primarily by the daily moving averages and monthly indicators.\n\nIn terms of performance, the stock has returned 66.06% year-to-date, significantly outperforming the S&P 500's 12.22%, but has underperformed over the past year with a return of -24.79% compared to the S&P 500's 17.14%...."
      },
      {
        "title": "Is Agenus, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-agenus-inc-overvalued-or-undervalued-3542434",
        "imagepath": "",
        "date": "2025-09-20 17:52:39",
        "description": "As of 8 November 2022, the valuation grade for Agenus, Inc. has moved from fair to risky, indicating a shift towards a more negative outlook. The company appears to be overvalued, particularly given its troubling financial ratios, including a Price to Book Value of -0.48, an EV to EBIT of -4.84, and an EV to EBITDA of -5.54. These figures suggest significant financial distress compared to its peers, such as AnaptysBio, Inc. with an EV to EBITDA of -8.2275 and Entrada Therapeutics, Inc. at 1.6353, both of which are also classified as risky but show relatively better metrics.\n\nIn terms of stock performance, Agenus has underperformed against the S&P 500 across multiple time frames, with a staggering 3-year return of -90.09% compared to the S&P's 70.41%, and a 5-year return of -95.52% versus 96.61% for the index. This stark contrast reinforces the notion that Agenus is currently overvalued in the market...."
      }
    ],
    "total": 7,
    "sid": "1149895",
    "stock_news_url": "https://www.marketsmojo.com/news/agenus-inc-1149895"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Agenus, Inc. technically bullish or bearish?

2025-09-20 19:17:53

As of 3 September 2025, the technical trend for Agenus, Inc. has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly MACD and Bollinger Bands are mildly bearish, creating a mixed signal. The monthly MACD and KST are mildly bullish, suggesting some positive momentum over a longer time frame. Overall, the technical stance is mildly bullish, driven primarily by the daily moving averages and monthly indicators. In terms of performance, the stock has returned 66.06% year-to-date, significantly outperforming the S&P 500's 12.22%, but has underperformed over the past year with a return of -24.79% compared to the S&P 500's 17.14%....

Is Agenus, Inc. overvalued or undervalued?

2025-09-20 17:52:39

As of 8 November 2022, the valuation grade for Agenus, Inc. has moved from fair to risky, indicating a shift towards a more negative outlook. The company appears to be overvalued, particularly given its troubling financial ratios, including a Price to Book Value of -0.48, an EV to EBIT of -4.84, and an EV to EBITDA of -5.54. These figures suggest significant financial distress compared to its peers, such as AnaptysBio, Inc. with an EV to EBITDA of -8.2275 and Entrada Therapeutics, Inc. at 1.6353, both of which are also classified as risky but show relatively better metrics. In terms of stock performance, Agenus has underperformed against the S&P 500 across multiple time frames, with a staggering 3-year return of -90.09% compared to the S&P's 70.41%, and a 5-year return of -95.52% versus 96.61% for the index. This stark contrast reinforces the notion that Agenus is currently overvalued in the market....

View All News